Arboretum LifeSciences, Inc.

Precision Medicine · Health Care
Lately:4 news stories in 90 daysFollow changes →

Facts

as of Nov 19, 2026

Arboretum is a new approach to precision medicine for common diseases, bringing smarter diagnostics, efficient trials, and better care for millions.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Newsroom

Oct 92026
News · MedCity News
Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the b…
Oct 62026
News · Pulse 2.0
Arboretum LifeSciences has launched with $30 million in Series A funding to expand access to genetic testing for common diseases and build a molecular information platform suppor…
Oct 62026
News · Amgen-Aktie: Amgen als Investor bei Arboretum LifeSciences
Amgen gehört zu den Investoren des neu gestarteten Biotechnologieunternehmens Arboretum LifeSciences. Die Series-A-Finanzierung umfasst 30 Millionen US-Dollar.
Sources: the outlets named on each headline, each story once